These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7173317)

  • 1. The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat.
    Dyck LE; Kazakoff CW; Dourish CT
    Eur J Pharmacol; 1982 Oct; 84(3-4):139-49. PubMed ID: 7173317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.
    Dourish CT
    Br J Pharmacol; 1982 Sep; 77(1):129-39. PubMed ID: 6982090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of a rat behavioral model for serotonin receptor activation.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):339-47. PubMed ID: 682117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regional distribution of p-tyramine and m-tyramine in the rat corpus striatum and the effect of monoamine oxidase inhibition.
    Sardar A; Juorio AV
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):309-13. PubMed ID: 3628835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT.
    Stoessl AJ; Dourish CT; Iversen SD
    Brain Res; 1990 May; 517(1-2):111-6. PubMed ID: 1695859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long lasting supersensitivity to 5-HT mediated behaviour following monoamine depletion in the rat brain.
    Rényi L
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):298-302. PubMed ID: 2948371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase.
    Palfreyman MG; Mir AK; Kubina M; Middlemiss DN; Richards M; Tricklebank MD; Fozard JR
    Eur J Pharmacol; 1986 Oct; 130(1-2):73-89. PubMed ID: 3780861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxytryptamine-mediated behaviour in male and female rats.
    Dickinson SL; Curzon G
    Neuropharmacology; 1986 Jul; 25(7):771-6. PubMed ID: 3748324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitatory and inhibitory effects of harmaline on the tryptophan-induced 5-hydroxytryptamine syndrome and body temperature changes in pargyline-pretreated rats.
    Abdel-Fattah AF; Matsumoto K; Murakami Y; El-Hady KA; Mohamed MF; Watanabe H
    Jpn J Pharmacol; 1996 Sep; 72(1):39-47. PubMed ID: 8902598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of p-nitromethylamphetamine on biogenic amines and their amino-acid precursors in rat brain.
    Leonard BE; Shallice SA
    Br J Pharmacol; 1971 Dec; 43(4):732-8. PubMed ID: 5152025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.
    Claassen V; Davies JE; Hertting G; Placheta P
    Br J Pharmacol; 1977 Aug; 60(4):505-16. PubMed ID: 302726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats.
    Kuhn DM; Wolf WA; Youdim MB
    Br J Pharmacol; 1985 Jan; 84(1):121-9. PubMed ID: 2579697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural and neurochemical effects of meta-tyrosine in the rat.
    Dyck LE; Kazakoff CW; Dourish CT
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):389-94. PubMed ID: 6891806
    [No Abstract]   [Full Text] [Related]  

  • 17. Biosynthesis and metabolism of endogenous tyramine and its normal presence in sympathetic nerves.
    Tallman JF; Saavedra JM; Axelrod J
    J Pharmacol Exp Ther; 1976 Oct; 199(1):216-21. PubMed ID: 10424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat brain serotonin: biochemical and functional evidence for a sex difference.
    Carlsson M; Svensson K; Eriksson E; Carlsson A
    J Neural Transm; 1985; 63(3-4):297-313. PubMed ID: 2415675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways linking L-phenylalanine and 2-phenylethylamine with p-tyramine in rabbit brain.
    Silkaitis RP; Mosnaim AD
    Brain Res; 1976 Sep; 114(1):105-15. PubMed ID: 963535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution.
    Dourish CT; Dewar KM; Dyck LE; Boulton AA
    Psychopharmacology (Berl); 1983; 81(2):122-5. PubMed ID: 6415742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.